Article info
Therapeutics
Cost-effectiveness analysis
Daily self-monitoring unlikely to be cost-effective in adults with type 2 diabetes not using insulin in Canada
- Correspondence to Mayer B Davidson
Charles R. Drew University, 1731 East 120th Street, Los Angeles, CA 90059, USA; mayerdavidson{at}cdrewu.edu
Citation
Daily self-monitoring unlikely to be cost-effective in adults with type 2 diabetes not using insulin in Canada
Publication history
- First published June 3, 2010.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions